-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Tengjun Biotechnology Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2022 to Q2 2023.
- Tengjun Biotechnology Corp. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was -$2.26K, a 100% decline year-over-year.
- Tengjun Biotechnology Corp. Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $2.9M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)